Stay informed with the latest updates for the inheritable blood disorders community. Industry BioMarin Reports Continued Progress in Clinical Trial for…Aug 1, 2017 Industry Octapharma USA Funds National Camp Exchange for Bleeding Disorders CampsJul 13, 2017 Industry Alnylam and Sanofi Report Positive Trial Updates for FitusiranJul 11, 2017 Industry Shire Submits IND Application for Hemophilia A Gene Therapy CandidateJul 10, 2017 Industry Genentech Announces Progress in Two Phase III Emicizumab StudiesJul 5, 2017 Industry FDA Approves Biologics License Application for Novo Nordisk’s…Jun 2, 2017 Industry Investigational Therapy for Hemophilia A Comes up Short in TrialJun 2, 2017 Industry Genentech Announces Positive Interim Trial Results for EmicizumabApr 17, 2017 Industry Grifols Increases Commitment of Factor VIII DonationsApr 17, 2017 Industry Spark Reports Progress in Hemophilia B Gene Therapy TrialApr 11, 2017 Industry Shire’s Phase 3 Trial Will Evaluate PK-Guided Prophylaxis with ADYNOVATE®Mar 8, 2017 Industry Spark Therapeutics Announces Initiation of Phase 1/2 Trial Feb 23, 2017 Industry Important Statement on HAVEN 1 Clinical TrialFeb 22, 2017 IndustryFDA Accepts New Drug Application for AbbiVie’s HCV Combination TherapyFeb 7, 2017 Industry Bioverativ an Independent Company Spun off from BiogenFeb 2, 2017 Pagination First page Previous page … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page Last page
